Psychedelic Drugs

A new study suggests that emergency visits involving hallucinogens could be a warning sign for future schizophrenia, especially among younger adults.

A new brain imaging study finds LSD alters brain connectivity in unique ways, setting it apart from MDMA and amphetamine despite some shared effects.

A new case report describes how two multiple sclerosis patients showed reduced brain lesions and symptom improvement following ibogaine treatment.

Microdosing LSD has no clear benefit for ADHD, according to a new placebo-controlled clinical trial published in JAMA Psychiatry.

A study of British adults found that those who had used psychedelics were 25% less likely to report frequent bad headaches, adding to growing research on psychedelics’ potential medical benefits.

Does psilocybin affect everyone the same way? New research suggests that race and ethnicity may play a role in the long-term benefits of this psychedelic substance.

Recent findings suggest that ayahuasca improves detailed memory recall among experienced users without altering overall familiarity.

A single dose of psilocybin significantly increased emotional empathy in depressed individuals for up to two weeks.

Feelings of shame and guilt are surprisingly common during psilocybin experiences, affecting most users. However, a new study reveals that constructively working through these emotions, rather than avoiding them, is linked to improved wellbeing afterward.

A study found that harmine, a key component of ayahuasca, has no significant psychoactive effects at doses up to 500 mg. While some participants experienced drowsiness and mild side effects, harmine did not induce hallucinations or major mental status changes.

Can psychedelics help autistic adults? A new study reveals some report benefits like reduced anxiety and better social connection, but also highlights potential downsides.

In moments of crisis, deep focus, or psychedelic exploration, seconds can morph into minutes. This isn't just memory playing tricks. "Time expansion experiences" reveal a profound link between consciousness and our perception of reality.

Recent research found that the psychedelic drug DOI reduced heroin-seeking behavior in rats by lowering their motivation to obtain heroin. This effect was mediated through 5-HT2A receptors, suggesting DOI’s potential therapeutic role in opioid use disorder treatment.

Recent research found that psychedelic users had lower death anxiety, but this was linked to transcendent experiences rather than the substances themselves.

An ethnographic study in Alabama found that participants in peyote ceremonies reported reduced substance misuse, improved mental and physical health, and new life perspectives.